MedPath

贵州百灵企业集团和仁堂药业有限公司

Ownership
-
Established
2001-07-13
Employees
-
Market Cap
-
Website
www.gzhrtyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

NMPA:10

Drug Approvals

洁阴灵洗剂

Approval Number
国药准字Z20026462
Approval Date
Sep 6, 2024
NMPA

泌淋清胶囊

Approval Number
国药准字Z20026567
Approval Date
Sep 4, 2024
NMPA

咳清胶囊

Approval Number
国药准字Z20025223
Approval Date
Sep 4, 2024
NMPA

小儿氨酚烷胺颗粒

Approval Number
国药准字H52020604
Approval Date
Aug 27, 2024
NMPA

Paracetamol Tablets

Product Name
对乙酰氨基酚片
Approval Number
国药准字H52020651
Approval Date
Nov 14, 2019
NMPA

Compound Paracetamol and Amantadine Hydrochloride Capsules

Product Name
复方氨酚烷胺胶囊
Approval Number
国药准字H52020179
Approval Date
Nov 14, 2019
NMPA

康妇灵片

Approval Number
国药准字Z20090968
Approval Date
Nov 14, 2019
NMPA

咽炎清片

Approval Number
国药准字Z20025403
Approval Date
Sep 2, 2019
NMPA

康妇灵胶囊

Approval Number
国药准字Z20025767
Approval Date
Sep 2, 2019
NMPA

胃可安胶囊

Approval Number
国药准字Z20026303
Approval Date
Aug 30, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.